Lynparza (olaparib) is an advanced cancer treatment drug
… AstraZeneca and Merck Lynparza (olaparib) Gain Another Oncology Indication In Men’s Health …

LYNPARZA (olaparib) GAINS NEW PROSTATE CANCER INDICATION

AstraZeneca and Merck Collaboration Continues To Pay Off For Patients, Oncologists, Urologists And Investors

Lynparza’s FDA approval features a requirement for testing to specifically identify appropriate patients to be treated based on the indication

Prostate cancer is a global healthcare challenge

AstraZeneca and Merck can further optimize Lynparza’s market access strategy and revenue streams in oncology

The AstraZeneca and Merck collaboration is a clinically and commercially successful partnership

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Bare Sky Marketing — Healthcare Content Writing

Authentic, fact-based healthcare content marketing writing for medical, business, academic, patient and consumer audiences https://www.BareSkyMarketing.com/